26
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Multi-scale and multi-parametric radiomics of gadoxetate disodium–enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma ≤ 5 cm

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objectives

          To develop radiomics-based nomograms for preoperative microvascular invasion (MVI) and recurrence-free survival (RFS) prediction in patients with solitary hepatocellular carcinoma (HCC) ≤ 5 cm.

          Methods

          Between March 2012 and September 2019, 356 patients with pathologically confirmed solitary HCC ≤ 5 cm who underwent preoperative gadoxetate disodium–enhanced MRI were retrospectively enrolled. MVI was graded as M0, M1, or M2 according to the number and distribution of invaded vessels. Radiomics features were extracted from DWI, arterial, portal venous, and hepatobiliary phase images in regions of the entire tumor, peritumoral area ≤ 10 mm, and randomly selected liver tissue. Multivariate analysis identified the independent predictors for MVI and RFS, with nomogram visualized the ultimately predictive models.

          Results

          Elevated alpha-fetoprotein, total bilirubin and radiomics values, peritumoral enhancement, and incomplete or absent capsule enhancement were independent risk factors for MVI. The AUCs of MVI nomogram reached 0.920 (95% CI: 0.861–0.979) using random forest and 0.879 (95% CI: 0.820–0.938) using logistic regression analysis in validation cohort ( n = 106). With the 5-year RFS rate of 68.4%, the median RFS of MVI-positive (M2 and M1) and MVI-negative (M0) patients were 30.5 (11.9 and 40.9) and > 96.9 months ( p < 0.001), respectively. Age, histologic MVI, alkaline phosphatase, and alanine aminotransferase independently predicted recurrence, yielding AUC of 0.654 (95% CI: 0.538–0.769, n = 99) in RFS validation cohort. Instead of histologic MVI, the preoperatively predicted MVI by MVI nomogram using random forest achieved comparable accuracy in MVI stratification and RFS prediction.

          Conclusions

          Preoperative radiomics-based nomogram using random forest is a potential biomarker of MVI and RFS prediction for solitary HCC ≤ 5 cm.

          Key Points

          The radiomics score was the predominant independent predictor of MVI which was the primary independent risk factor for postoperative recurrence.

          The radiomics-based nomogram using either random forest or logistic regression analysis has obtained the best preoperative prediction of MVI in HCC patients so far.

          As an excellent substitute for the invasive histologic MVI, the preoperatively predicted MVI by MVI nomogram using random forest (MVI-RF) achieved comparable accuracy in MVI stratification and outcome, reinforcing the radiologic understanding of HCC angioinvasion and progression.

          Supplementary Information

          The online version contains supplementary material available at 10.1007/s00330-020-07601-2.

          Related collections

          Most cited references44

          • Record: found
          • Abstract: not found
          • Article: not found

          EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Hepatocellular carcinoma

            Hepatocellular carcinoma appears frequently in patients with cirrhosis. Surveillance by biannual ultrasound is recommended for such patients because it allows diagnosis at an early stage, when effective therapies are feasible. The best candidates for resection are patients with a solitary tumour and preserved liver function. Liver transplantation benefits patients who are not good candidates for surgical resection, and the best candidates are those within Milan criteria (solitary tumour ≤5 cm or up to three nodules ≤3 cm). Image-guided ablation is the most frequently used therapeutic strategy, but its efficacy is limited by the size of the tumour and its localisation. Chemoembolisation has survival benefit in asymptomatic patients with multifocal disease without vascular invasion or extrahepatic spread. Finally, sorafenib, lenvatinib, which is non-inferior to sorafenib, and regorafenib increase survival and are the standard treatments in advanced hepatocellular carcinoma. This Seminar summarises the scientific evidence that supports the current recommendations for clinical practice, and discusses the areas in which more research is needed.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Hepatocellular Carcinoma

                Bookmark

                Author and article information

                Contributors
                dryangchun@hotmail.com
                mengsu_zeng@163.com
                Journal
                Eur Radiol
                Eur Radiol
                European Radiology
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                0938-7994
                1432-1084
                14 January 2021
                14 January 2021
                2021
                : 31
                : 7
                : 4824-4838
                Affiliations
                [1 ]Shanghai Institute of Medical Imaging, 180 Fenglin Road, Shanghai, China
                [2 ]GRID grid.413087.9, ISNI 0000 0004 1755 3939, Department of Radiology, , Zhongshan Hospital, Fudan University, ; 180 Fenglin Road, Shanghai, 200032 China
                [3 ]Shanghai United Imaging Intelligence Co., Ltd, Shanghai, China
                [4 ]GRID grid.8547.e, ISNI 0000 0001 0125 2443, Department of Medical Imaging, Shanghai Medical College, , Fudan University, ; Shanghai, China
                Author information
                http://orcid.org/0000-0002-0299-9407
                Article
                7601
                10.1007/s00330-020-07601-2
                8213553
                33447861
                4f41e93a-068a-456d-b4b6-74f6717801cf
                © The Author(s) 2021

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 22 August 2020
                : 28 October 2020
                : 3 December 2020
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100001809, National Natural Science Foundation of China;
                Award ID: 91859107
                Award Recipient :
                Funded by: National Key Research and Development Program of China
                Award ID: 2017YFC0108804
                Award Recipient :
                Funded by: Shanghai Science and Technology Committee
                Award ID: 18DZ1930102 and 19411965500
                Award Recipient :
                Funded by: Zhongshan Hospital, Fudan University
                Award ID: 2018ZSLC22
                Award Recipient :
                Funded by: Shanghai Municipal Key Clinical Specialty
                Award ID: W2019-018
                Award Recipient :
                Funded by: Youth Foundation of Shanghai Municipal Health Commission
                Award ID: 20204Y0346
                Award Recipient :
                Categories
                Hepatobiliary-Pancreas
                Custom metadata
                © European Society of Radiology 2021

                Radiology & Imaging
                hepatocellular carcinoma,magnetic resonance imaging,neoplasm recurrence

                Comments

                Comment on this article

                scite_

                Similar content76

                Cited by58

                Most referenced authors821